Phase 1/2A Study of Glutathione Pegylated Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (Bm) from Solid Tumors or Recurrent High Grade Gliomas (Hgg)
Dieta Brandsma(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Philippe Aftimos(Institut Jules Bordet), Carey K. Anders(Duke University), Hans Gelderblom(Leiden University Medical Center), Werner Gladdines(BBB Therapeutics (Netherlands)), Véronique Dièras(Institut Curie), Agnes Jager(Erasmus MC Cancer Institute), Fredrik Lönnqvist(Karolinska Institutet), Myra E. van Linde(Amsterdam Neuroscience), Patricia M.M.B. Soetekouw(Radboud University Nijmegen), Sevilay Altıntaş(Antwerp University Hospital), J. Schellens(Utrecht University), M Ballester(Institut Gustave Roussy), Bojana Milojkovic Kerklaan(Utrecht University)
Cited by 33
Related Papers
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Cremophor EL
|European Journal of Cancer|2001|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k